Home » Topics » BioWorld Science

BioWorld Science
RSS

OncoArendi Therapeutics discovers AMCase and CHIT1 inhibitors

Feb. 10, 2021

Shouyao Holdings (Beijing) identifies new Ret inhibitors

Feb. 10, 2021

Idorsia Pharmaceuticals discloses new antibacterials

Feb. 10, 2021

Teon Therapeutics patents new adenosine A2A receptor antagonists

Feb. 10, 2021

NSC-765690 and NSC-765599 show antitumor activity against NCI60 human tumor cell lines

Feb. 10, 2021

European Commission approves additional indication for clopidogrel

Feb. 10, 2021

Initiation of phase II study assessing IRX-2 plus pembrolizumab and chemotherapy in TNBC

Feb. 10, 2021

SorLA identified as a target in anti-HER2-resistant HER2-positive breast cancer

Feb. 10, 2021

Microbiome fungi counter systemic infections

Feb. 10, 2021

Predicting phase separation

Feb. 10, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...